about
Bypass surgery for chronic lower limb ischaemiaMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaRevealing the sequence and resulting cellular morphology of receptor-ligand interactions during Plasmodium falciparum invasion of erythrocytesA phase 1 trial of MSP2-C1, a blood-stage malaria vaccine containing 2 isoforms of MSP2 formulated with Montanide® ISA 720Peripheral artery disease: epidemiology and global perspectives.Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria.Presenting parasitological data: the good, the bad and the error bar.Increased microerythrocyte count in homozygous alpha(+)-thalassaemia contributes to protection against severe malarial anaemiaAcquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum.The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.Immunity as a predictor of anti-malarial treatment failure: a systematic reviewAntibody Responses to Plasmodium falciparum and Plasmodium vivax and Prospective Risk of Plasmodium spp. Infection Postpartum.Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysisIntermittent preventive treatment to reduce the burden of malaria in children: new evidence on integration and deliveryInfluence of the number and timing of malaria episodes during pregnancy on prematurity and small-for-gestational-age in an area of low transmission.Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans.Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates.Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced womenImmunological markers of Plasmodium vivax exposure and immunity: a systematic review and meta-analysisThe Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.Implications of the licensure of a partially efficacious malaria vaccine on evaluating second-generation vaccines.Research priorities for the development and implementation of serological tools for malaria surveillance.Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1.Scottish smoke-free legislation and trends in smoking cessation.Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of responseEpistatic Interactions between apolipoprotein E and hemoglobin S Genes in regulation of malaria parasitemia.The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic areaMaximizing antimalarial efficacy and the importance of dosing strategies.The impact of lipid-based nutrient supplementation on anti-malarial antibodies in pregnant women in a randomized controlled trial.Estimating Gestational Age in Late Presenters to Antenatal Care in a Resource-Limited Setting on the Thai-Myanmar Border.Malaria and immunity during pregnancy and postpartum: a tale of two speciesMalaria eradication and elimination: views on how to translate a vision into realityDifferences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malariaTargets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity.Inhibition of placental mTOR signaling provides a link between placental malaria and reduced birthweight.New insights into acquisition, boosting, and longevity of immunity to malaria in pregnant women.Individual variation in levels of haptoglobin-related protein in children from GabonMaternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting.Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.
P50
Q24243035-E6FC1777-B72A-4B72-AAE6-5FF256029C32Q26772878-F5B9935F-F01B-4CCD-BD45-1F456CD018AAQ27321307-D61610E4-E960-4E4A-AFF1-F173CAB69EC1Q28744696-1289A432-9CB7-47E0-89F7-3FB6CA0E87B6Q30241154-15D0835E-47E4-4B73-8415-85972CD8CD21Q30248811-1DA3D168-8C6C-447C-9EE1-C3F44363B365Q30977133-003C0B8F-7DDC-42E3-9F6D-94C893C1BB39Q33324482-BB6F11BC-BC7E-4F84-9CEF-97BAC2B30326Q33380204-2C4E9B6B-099C-410D-BC6E-8073E20E2F87Q33526349-7ED5D33A-EDD2-4D57-B7BF-56561FA2CFFBQ33582154-29BFA2FA-4C23-4892-9059-C17072E4B202Q33636850-F92CB934-2A99-4604-B3D8-2CB004EE07EDQ33654931-C21A60C4-F36D-4CC8-BC58-0F35398BF29CQ33815505-D3E1230E-81BD-4954-960E-22DC1B2004E3Q33820246-44D1A781-2E68-43AD-AE48-DFAECCF0104DQ33826049-E0AE6C6D-34AF-4C6E-8F73-38A71D262F3EQ34081745-D2DC4741-5C6C-47A8-8719-86EEB19BC722Q34161839-E1BBCDD1-1F47-4289-B696-5BA81E18A379Q34170093-002E9F00-32CE-4BAF-8292-59F1B2EF66DCQ34234390-C4617606-6757-4631-9609-05DFD85E5FF8Q34428497-91BA2E08-56C8-4CFD-A9EA-2B5ECAD4A7CEQ34478487-D71821DE-C298-4832-80DA-1A5C15B95B94Q34500035-3CDB2A98-D732-4486-BDDF-3BF60B557DBEQ34596157-4A19833F-AE6B-481C-92C0-B21CA1007231Q34888435-A0274128-1D2D-41A6-BAF0-E3371B16EF16Q34955461-8B814097-38E6-4F04-86AD-BE08B3DAA1E0Q35014977-33DA6918-1D7E-4DF1-86C6-1C9A93C7F968Q35579613-C70FC67B-269B-426F-A179-6086876304EAQ35588265-4F8E5393-3658-4238-A418-50D9DB99D34CQ35627041-60F541E5-A9DE-41B7-9C2D-B54EE9AFA1DCQ35675280-FAD0A180-34BD-4832-B313-71B987BE8173Q35678578-14BB3EC4-5B57-4128-974C-32C9262A1D6EQ35712522-88CAC647-8AF0-4BCB-8B1D-090B1F81F4FBQ36009883-25351602-7752-46C7-8A98-881A1DB4D619Q36190707-BE51B4BA-EBB5-4C62-8452-EA8D062CCF1FQ36238919-7323F34F-7544-4F00-8453-337932C22683Q36330969-4E7D23EA-5A2B-4C85-993C-C898C2769344Q36411897-20D60555-8A9B-44CE-8426-00411C47A59FQ36565070-5D8BC967-2834-4B44-880C-4A815A7014B1Q36809595-ECFADFAB-285D-447E-B1E1-9B7F49471703
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Freya Fowkes
@ast
Freya Fowkes
@en
Freya Fowkes
@es
Freya Fowkes
@nl
Freya Fowkes
@sl
type
label
Freya Fowkes
@ast
Freya Fowkes
@en
Freya Fowkes
@es
Freya Fowkes
@nl
Freya Fowkes
@sl
prefLabel
Freya Fowkes
@ast
Freya Fowkes
@en
Freya Fowkes
@es
Freya Fowkes
@nl
Freya Fowkes
@sl
P108
P106
P108
P1153
36850168400
P21
P31
P496
0000-0001-5832-9464